| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/03/2007 | EP1737829A2 Preparation of rosuvastatin |
| 01/03/2007 | EP1737828A1 Amorphous magnesium salts of rosuvastatin |
| 01/03/2007 | EP1737826A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 01/03/2007 | EP1737463A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737462A1 Pyrimidines with tie2 (tek) activity |
| 01/03/2007 | EP1737451A2 Monocyclic heterocycles as kinase inhibitors |
| 01/03/2007 | EP1651618B1 2-substituted pyrimidines |
| 01/03/2007 | EP1277726B1 Process for the preparation of 2-halobenzoic acids |
| 01/03/2007 | EP1265850B1 Insecticidal anthranilamides |
| 01/03/2007 | CN1890246A Pyrazolopyrimidines |
| 01/03/2007 | CN1890223A Capsaicin receptor agonists |
| 01/03/2007 | CN1890222A Method for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/03/2007 | CN1890216A Carboxamide derivatives |
| 01/03/2007 | CN1889947A Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/03/2007 | CN1887877A Thirteen-eliment nanometer RE anticancer compound and its prepn and application |
| 01/03/2007 | CN1887876A Nanometer RE heterocyclic anticancer compound and its prepn and application |
| 01/03/2007 | CN1887847A Substituted p-trifluoromethyl phenyl ether compound and its prepn and application |
| 01/03/2007 | CN1293078C Imidazo fused compounds |
| 01/03/2007 | CN1293060C Substituted aryl sulphonyl(thio)ureas used as herbicides |
| 01/03/2007 | CN1293059C New Carboxglic acid derivative, its preparation and application |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/02/2007 | US7157581 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157467 Therapeutic use |
| 01/02/2007 | US7157461 For therapy of hypertension |
| 01/02/2007 | US7157455 4-Aminopyrimidine-5-one derivatives |
| 01/02/2007 | US7157442 Antibacterial compound |
| 01/02/2007 | US7157430 (Substituted)acyl dipeptidyl inhibitors of the ICE/CED-3 family of cysteine proteases |
| 01/02/2007 | CA2289817C 2-amino-4-alkylamino-3-pyrimidine oxides as soothing agents |
| 12/28/2006 | WO2006138217A1 Aspartyl protease inhibitors |
| 12/28/2006 | WO2006137450A1 Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 12/28/2006 | WO2006137421A1 Agent for topical administration |
| 12/28/2006 | WO2006136857A1 Dihydropyrimidone multimers and their use as human neutrophil elastase inhibitors |
| 12/28/2006 | WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | WO2006136408A2 Process for preparing pure amorphous rosuvastatin calcium |
| 12/28/2006 | WO2006136407A1 Process for preparing amorphous rosuvastatin calcium free of impurities |
| 12/28/2006 | WO2006136327A1 Fungicidal benzylpyrimidine derivatives |
| 12/28/2006 | WO2006121648A3 Method for preparation of optionally 2-substituted 1,6-dihydro-6-oxo-4-pyrimidinecarboxylic acids |
| 12/28/2006 | WO2006097617A3 Novel dihydropyrimidine derivatives and their use as anti-cancer agents |
| 12/28/2006 | US20060293520 Mehtod for producing 3-phenyl(thio)uracils and 3-phenyldithiouracils |
| 12/28/2006 | US20060293355 Crystalline form of bis [(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s)-3, 5-dihydroxyhept-6-enoicacid] calcium salt |
| 12/28/2006 | US20060293354 Pyrimidine derivatives and their use as CB2 modulators |
| 12/28/2006 | US20060293353 Matrix metalloproteinase inhibitors |
| 12/28/2006 | US20060293350 such as 8-methoxy-4-methyl-3,4-dihydro-quinazolin-2-ylamine, serotonin receptor antagonists used for the treating schizophrenia, sexual dysfunction, obsessive compulsive, post-traumatic stress, sleep, eating, gastrointestinal and psychological disorders, as anxiolytic agents, antidepressants, analgesics |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293340 2-Aminopyrimidine derivatives as raf kinase inhibitors |
| 12/28/2006 | US20060293339 Biaryl substituted 6-membered heterocycles as sodium channel blockers |
| 12/28/2006 | US20060293310 Derivatives of 1-piperazine-and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the FAAH enzyme |
| 12/28/2006 | US20060293289 Moderator of neurotransmitters releasing; analgesics ; central nervous system disorders; using N-methyl-5-(5-methoxy-3-pyridyl)-4-penten-2-amine |
| 12/28/2006 | CA2613249A1 Crystals of phenylalanine derivatives, production method thereof and use thereof |
| 12/28/2006 | CA2612587A1 Process for preparing amorphous rosuvastatin calcium free of impurities |
| 12/28/2006 | CA2612227A1 Pyrimidine compounds |
| 12/28/2006 | CA2611920A1 Process for preparing pure amorphous rosuvastatin calcium |
| 12/28/2006 | CA2610815A1 Aspartyl protease inhibitors |
| 12/28/2006 | CA2610742A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736466A1 Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1735270A1 Diamino alcohols and their use as renin inhibitors |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1734825A1 5,6-cycloalkyl-7-aminotriazolopyrimidines, method for production and use thereof for the prevention of fungal pests and agents comprising the same |
| 12/27/2006 | EP1608317A4 Dipeptidyl peptidase inhibitors |
| 12/27/2006 | EP1436267B1 Lactam derivatives as antagonists for human 11cby receptors |
| 12/27/2006 | EP1417180B1 Preparation of aminopyrimidine compounds |
| 12/27/2006 | EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | EP1007011B1 Lock and key micelles |
| 12/27/2006 | CN1886385A Crystals of phenylalanine derivatives and production methods thereof |
| 12/27/2006 | CN1886384A Quinazolinone compounds as anticancer agents |
| 12/27/2006 | CN1886383A Process for the preparation of amorphous rosuvastatin calcium |
| 12/27/2006 | CN1886382A Substituted dihydropyrimidinone preparation using polyaniline salt catalyst |
| 12/27/2006 | CN1886381A Method for producing acyl urea derivatives, salts of said acyl urea derivatives, and the use thereof as pesticides |
| 12/27/2006 | CN1884280A Process for the preparation of piribedil |
| 12/27/2006 | CN1291720C Non-sedating barbituric acid derivatives |
| 12/26/2006 | US7154002 Phenylglycinamide derivatives containing a substituent capable of complexing with a protein metal ion, particularly an acrylhydroxamic group, e.g., 3-(3-{Benzylcarbamoyl-[formyl-(4-phenoxy-phenyl)-amino]-methyl}-phenyl)-N-hydroxy-acrylamide; antiproliferative agents |
| 12/26/2006 | US7153964 Pyrimidine compounds |
| 12/26/2006 | US7153963 Phenylalanine derivatives |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153862 αv integrin receptor antagonists |
| 12/26/2006 | US7153861 5,6 -Trimethylenepyrimidin-4-one compounds |
| 12/26/2006 | US7153860 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 12/26/2006 | US7153858 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative |
| 12/21/2006 | WO2006135763A2 Inhibitors of dna repair enzymes and methods of use thereof |
| 12/21/2006 | WO2006135719A1 Aminopyrimidines as kinase modulators |
| 12/21/2006 | WO2006135312A1 Trombin inhibiting 2,4-dioxo-3,4-dihydropyrimidine derivatives |
| 12/21/2006 | WO2006133822A1 Method for producing dihydroquinazolines |
| 12/21/2006 | WO2006034235A3 Substituted quinoline and quinazoline inhibitors of quinone reductase 2 |
| 12/21/2006 | US20060287527 Process for producing acrylic acid derivative |
| 12/21/2006 | US20060287525 For post-chemotherapy or post-operative surgery nausea and vomitting; sustained release |
| 12/21/2006 | US20060287338 Metalloproteinase inhibitor compounds |
| 12/21/2006 | US20060287326 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 12/21/2006 | US20060287321 Novel Lactam Derivatives |
| 12/21/2006 | US20060287308 3-Aminoquinazolin-2,4-dione antibacterial agents |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | DE102005027517A1 Verfahren zur Herstellung von Dihydrochinazolinen Process for the preparation of dihydroquinazolines |